# Secondary Use of PARALLEL-HF Data

> **NCT07527767** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 236 (actual)

## Conditions studied

- Chronic Heart Failure and Reduced Ejection Fraction (HFrEF)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07527767
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-27
- **Primary completion:** 2023-12-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07527767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07527767, "Secondary Use of PARALLEL-HF Data". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07527767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*